Company profile
Clemedi company profile
Clemedi develops in vitro diagnostic tests for infectious diseases, by uniting two novel technologies – Next-generation Sequencing and Machine learning. They will contribute to limiting deaths caused by antibiotic resistant bacteria, projected to reach 10 million annually in 2050! Our diagnostic tests support doctors’ decision-making by enabling him or her to give a timely and personalized antibiotic therapy. Ultimately, patients suffering from infectious diseases will benefit with their product.
Business identity
- Website
- https://clemedi.com/
- Contact email
- [email protected]
- Phone number
- +41 77 98 040 61
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Country code
- CH
- Continent
- Europe